A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study)

2012 ◽  
Vol 48 (5) ◽  
pp. 713-720 ◽  
Author(s):  
C. Sebban ◽  
A. Lefranc ◽  
L. Perrier ◽  
P. Moreau ◽  
D. Espinouse ◽  
...  
Keyword(s):  
Stem Cell ◽  
Cost Effectiveness ◽  
Phase Ii ◽  
Stem Cell Transplant ◽  
Phase Ii Study ◽  
Autologous Stem Cell Transplant ◽  
Cell Transplant

scholarly journals Phase II study of bryostatin 1 and vincristine for aggressive non-Hodgkin lymphoma relapsing after an autologous stem cell transplant

2009 ◽  
Vol 84 (8) ◽  
pp. 484-487 ◽  
Author(s):  
Paul M. Barr ◽  
Hillard M. Lazarus ◽  
Brenda W. Cooper ◽  
Mark D. Schluchter ◽  
Ashok Panneerselvam ◽  
...  
Keyword(s):  
Stem Cell ◽  
Hodgkin Lymphoma ◽  
Phase Ii ◽  
Stem Cell Transplant ◽  
Phase Ii Study ◽  
Autologous Stem Cell Transplant ◽  
Cell Transplant ◽  
Bryostatin 1 ◽  
Non Hodgkin Lymphoma
Sign in / Sign up

Export Citation Format

Share Document